{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:41:31Z","timestamp":1791189691329,"version":"4.1.0"},"reference-count":101,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:00:00Z","timestamp":1418601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2015,1]]},"abstract":"<jats:p>Asthma remains one of the most prevalent and costly diseases in the United States. Asthma accounts for a significant amount of direct medical expenditures and indirect cost from days lost at school and work. Modern understanding of its complex pathogenesis has allowed recognition of the heterogeneity of the disease across populations and the various inflammatory pathways that drive airway inflammation in asthma. Interleukins play important roles in both eosinophilic and noneosinophilic asthma, and anti\u2010interleukin therapy will allow for a targeted, personalized approach to asthma management. With the success of anti\u2010interleukin (IL) \u20104, IL\u20105, and IL\u201013 therapy in recent large trials among specific populations of asthmatics, it is likely that targeted anti\u2010interleukin therapy will be approved for use in the near future. It will be important for clinicians and pharmacists to understand their risks, benefits, and proper indications.<\/jats:p>","DOI":"10.1002\/cpt.11","type":"journal-article","created":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T16:46:13Z","timestamp":1423673173000},"page":"55-65","source":"Crossref","is-referenced-by-count":23,"title":["Anti\u2010Interleukin Therapy in Asthma"],"prefix":"10.1111","volume":"97","author":[{"given":"RM","family":"Dunn","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine National Jewish Health Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ME","family":"Wechsler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine National Jewish Health Denver Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"e_1_2_5_1_1","unstructured":"Center for Disease Control.Asthma's impact on the nation. [updated 7 August 2014]. <http:\/\/www.cdc.gov\/asthma\/impacts_nation\/default.htm> (2014)."},{"key":"e_1_2_5_2_1","unstructured":"Center for Disease Control.Asthma in the US vital signs [Online 2011] [updated May 2011]. <http:\/\/www.cdc.gov\/vitalsigns\/asthma\/> (2011)."},{"key":"e_1_2_5_3_1","first-page":"1","article-title":"National surveillance for asthma\u2010\u2010United States, 1980\u20132004","volume":"56","author":"Moorman J.E.","year":"2007","journal-title":"MMWR Surveill. Summ."},{"key":"e_1_2_5_4_1","first-page":"1","article-title":"Trends in asthma prevalence, health care use, and mortality in the United States, 2001\u20132010","author":"Akinbami L.J.","year":"2012","journal-title":"NCHS Data Brief"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR\u20103): guidelines for the diagnosis and management of asthma\u2010summary report 2007","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"#cr-split#-e_1_2_5_6_1.1","unstructured":"GINA Report Global Strategy for Asthma Managment and Prevention 2014[updated August 2014"},{"key":"#cr-split#-e_1_2_5_6_1.2","unstructured":"cited 2 September 2014]. <http:\/\/www.ginasthma.org\/local\/uploads\/files\/GINA_Report_2014_Aug12.pdf> (2014)."},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008770"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.08.009"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.10.025"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct055184"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009705"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.126722"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2737"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200939778"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075021"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.12166"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199201303260504"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(07)96002-2"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2011.02576.x"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1159\/000069456"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115524"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3838"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000350662"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2005.12.067"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2011.01020.x"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08901"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.84.19.6629"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01445.x"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.05.031"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.02.006"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.03.048"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9610033"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.157.1.9703027"},{"key":"e_1_2_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03496-6"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200206-525OC"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-085OC"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805435"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808991"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.11.026"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403291"},{"key":"e_1_2_5_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403290"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0396OC"},{"key":"e_1_2_5_44_1","unstructured":"Bjermer L. Lemiere C. Maspero J. Ciesielska M. O'Brien C.&Zangrilli J.A randomized phase 3 study of the efficacy and safety of reslizumab in subjects with asthma with elevated eosinophils. (Abstract presented at European Respiratory Society Meeting 2014). 7 September2014."},{"key":"e_1_2_5_45_1","unstructured":"Corren J. Weinstein S. Janka L. O'Brien C.&Zangrilli J.A randomized phase 3 study of reslizumab efficacy in relation to blood eosinophil levels in patients with moderate to severe asthma. (Abstract presented at European Respiratory Society meeting 2014). 8 September2014."},{"key":"e_1_2_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.004"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.05.020"},{"key":"e_1_2_5_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.04.005"},{"key":"e_1_2_5_49_1","unstructured":"Clinicaltrials.gov.A phase 3a repeat dose open\u2010label long\u2010term safety study of mepolizumab in asthmatic subjects. <http:\/\/clinicaltrials.gov\/show\/NCT02135692> (2014). Accessed 2 September 2014."},{"key":"e_1_2_5_50_1","unstructured":"Clinicaltrials.gov.A study to determine long\u2010term safety of mepolizumab in asthmatic subjects.<http:\/\/clinicaltrials.gov\/show\/NCT01842607> (2014). Accessed 7 September 2014."},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1993.tb05927.x"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)70028-9"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.01.005"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5909"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00380.2003"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7276"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.02.046"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106469"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.03.051"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12220"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00223411"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2006.00960.x"},{"key":"e_1_2_5_63_1","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.12.3.7873190"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/rr40"},{"key":"e_1_2_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cr.7310002"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.6.9808146"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.115624"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01973.x"},{"key":"e_1_2_5_69_1","unstructured":"Clinicaltrials.gov.PIlot study in patients with symptomatic steroid\u2010naive asthma. <http:\/\/clinicaltrials.gov\/show\/NCT00024544> (2012)."},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.9.5792"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61600-6"},{"key":"e_1_2_5_72_1","unstructured":"Babatunde A.O.et al.A phase 2b study of inhaled pitrakinra an IL\u20104\/IL\u201013 antagonist successfully identified responder subpopulations of patients with uncontrolled asthma. D101 Asthma Genetics. American Thoracic Society International Conference Abstracts: American Thoracic Society. p. A6179\u2010A."},{"key":"e_1_2_5_73_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200909-1448OC"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"e_1_2_5_75_1","unstructured":"Clinicaltrials.gov.Long\u2010term safety evaluation of dupilumab in patients with asthma. <http:\/\/clinicaltrials.gov\/show\/NCT02134028> (2014). Accessed 2 September 2014."},{"key":"e_1_2_5_76_1","doi-asserted-by":"publisher","DOI":"10.1053\/rmed.2003.1507"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1159\/000049511"},{"key":"e_1_2_5_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-135"},{"key":"e_1_2_5_79_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.6.4089"},{"key":"e_1_2_5_80_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1109017"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2318OC"},{"key":"e_1_2_5_82_1","unstructured":"Clinicaltrials.gov.Safety tolerability and efficacy of AIN457 in patients with uncontrolled asthma.<http:\/\/clinicaltrials.gov\/show\/NCT01478360> (2014). Accessed 2 September 2014."},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.7.3983"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115383"},{"key":"e_1_2_5_85_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.106.2.400"},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200708-1200OC"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0213696"},{"key":"e_1_2_5_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(00)90185-4"},{"key":"e_1_2_5_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-14-93"},{"key":"e_1_2_5_90_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00451.2005"},{"key":"e_1_2_5_91_1","doi-asserted-by":"publisher","DOI":"10.1159\/000237350"},{"key":"e_1_2_5_92_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3.926"},{"key":"e_1_2_5_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2012.04014.x"},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.07.051"},{"key":"e_1_2_5_95_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200805-666OC"},{"key":"e_1_2_5_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.12.935"},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402895"},{"key":"e_1_2_5_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1247"},{"key":"e_1_2_5_99_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008961"},{"key":"e_1_2_5_100_1","unstructured":"Kaye J.Study of TLR\u20109 agonist for treatment of allergic asthma discontinued after disappointing results. (Healthcare Professionals Network 2014)."}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcpt.11","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:28:09Z","timestamp":1699363689000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":101,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.1002\/cpt.11"],"URL":"https:\/\/doi.org\/10.1002\/cpt.11","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}